ach03 marykay1NEW HAVEN: Mary Kay Fenton, executive vice president and chief financial officer of Achillion Pharmaceuticals inc [Nasdaq: ACHN], has been elected chair of CBIA’s board of directors.

Fenton succeeds John Ciulla, president of Webster Financial Corporation and Webster Bank, who becomes the immediate past chair.

The board also elected two vice chairs: Chris DiPentima, president of Middletown-based Pegasus Manufacturing, and Jennifer DelMonico, managing partner of Murtha Cullina LLP in New Haven.

“I am honored to lead the many talented CBIA directors across the state, all of whom are dedicated to creating, fostering, and sustaining a positive business climate,” Fenton said.

“Mary Kay is not only a distinguished leader in the biotech and healthcare sector, but maintains a longstanding commitment to making Connecticut a better place to live and work,” said CBIA president and CEO Joe Brennan.

Fenton is executive vice president and chief financial officer of Achillion leading Achillion’s financial and administrative function since company inception, Fenton is responsible for financial strategy and capital formation, financial reporting and compliance, and treasury and tax functions, as well as operating functions such as investor relations, risk management, facilities management, purchasing, and information technology.